Actio Biosciences, Inc.
Nina Kjellson is a General Partner at Canaan Partners and serves on the boards of several companies, including Actio Biosciences, Inc., Proxygen, Rondo Therapeutics, and Sardona Therapeutics. Nina Kjellson obtained a Bachelor of Arts in Human Biology from Stanford University, where studies were completed between 1992 and 1997, and received primary education at Phillips Exeter Academy.
This person is not in the org chart
This person is not in any teams
Actio Biosciences, Inc.
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.